CAS RN: 1261117-66-1
tert-butyl 2-(3-bromo-2-(4-fluorophenyl)-8,8-dimethyl-5,6-dihydroimidazo[1,2-a]pyrazin-7(8H)-yl)-2-oxoethylcarbamate
Product Availability
Choose a grade to view its available package options.
1 package records 1 with current stock 1 grade group
Grade
95% (1)
In stock only
Batch No. Package Availability Warehouse Inquiry
Batchno.20250806
100mg / 250mg / 500mg
Confirm by inquiry
Shanghai Inquiry
GET A QUOTE
This product has historical factory records. Recorded pack sizes and purity can be used as a supply reference, while project-specific availability is confirmed by inquiry.
Pack sizes on record: 1g
Available purity: ≥95%
Inventory rows with stock: 0
Bulk packaging: confirmed by inquiry
Request Bulk Quote
Recorded sizes, purity and stock details for CAS 1261117-66-1
Pack Size
Recorded Purity
Available Qty
Ship From
Inquiry
1g
≥95%
0
Out of Stock
Beijing
Inquiry
1261117-66-1 / tert-butyl N-[2-[3-bromo-2-(4-fluorophenyl)-8,8-dimethyl-5,6-dihydroimidazo[1,2-a]pyrazin-7-yl]-2-oxoethyl]carbamate
Standard CAS: 1261117-66-1
Multi CAS: No
Basic Information
copy
CAS
1261117-66-1 copy
Multi CAS
No copy
Molecular Formula
C21H26BrFN4O3 copy
Molecular Weight
481.400000 copy
Exact Mass
480.117230 copy
SMILES
CC1(C2=NC(=C(N2CCN1C(=O)CNC(=O)OC(C)(C)C)Br)C3=CC=C(C=C3)F)C copy
InChI
InChI=1S/C21H26BrFN4O3/c1-20(2,3)30-19(29)24-12-15(28)27-11-10-26-17(22)16(25-18(26)21(27,4)5)13-6-8-14(23)9-7-13/h6-9H,10-12H2,1-5H3,(H,24,29) copy
InChIKey
PGGHXAJROUEBSD-UHFFFAOYSA-N copy
Computed Properties
copy
Structural Parameters
Heavy atom count
30 copy
Aromatic heavy atom count
11 copy
Fraction Csp3
0.48 copy
Rotatable bonds
3 copy
H-bond acceptors
5 copy
H-bond donors
1 copy
Molar refractivity
114.3 copy
TPSA
76.46 copy
LogP / Solubility
WLOGP
4.05 copy
MLOGP
3.6 copy
XLogP3
3.2 copy
Consensus LogP
3.62 copy
Log S (ESOL)
-5.45 copy
Class (ESOL)
Slightly soluble copy
Log S (Ali)
-6.43 copy
Class (Ali)
Insoluble copy
Log S (SILICOS-IT)
-6.51 copy
Class (SILICOS-IT)
Insoluble copy
ADME
GI absorption
High copy
BBB permeant
No copy
P-gp substrate
No copy
CYP1A2 inhibitor
Yes copy
CYP2C19 inhibitor
Yes copy
CYP2C9 inhibitor
Yes copy
CYP2D6 inhibitor
Yes copy
CYP3A4 inhibitor
Yes copy
Log Kp (skin permeation)
-2.78 copy
Drug-likeness / Medicinal Chemistry
Lipinski
Yes copy
Ghose
No copy
Veber
Yes copy
Egan
Yes copy
Muegge
Yes copy
Bioavailability score
0.55 copy
Leadlikeness
No copy
Synthetic Accessibility
2.5 copy